Healthcare

Antacids Market is Likely to be Worth US$ 18.7 Bn by the end of 2025

Press Release

The global antacids market features a large number of companies, both international as well as regional, which serve the global market through a large number of products varieties and brands. The level of competition is thus intense and the high focus of companies on new markets and growth opportunities is evident through the several strategic collaborations to have taken place in the market in the past years, observes Transparency Market Research in a recent report.

Some of the leading companies in the market are Reckitt Benckiser Group plc, AstraZeneca, Valeant Pharmaceuticals International Inc., Boehringer Ingelheim GmbH, Bayer AG, GlaxoSmithKline plc, Sanofi, Pfizer Inc., Johnson & Johnson, Sun Pharmaceuticals Ltd., Procter & Gamble, Dr. Reddy’s Laboratories Ltd., and Takeda Pharmaceutical Company Ltd.

According to the report, the market is expected to exhibit a 3.7% CAGR from 2017 to 2025, rising to a valuation of US$18.7 bn by 2025.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=32864

Proton Pump Inhibitors Acquire Dominant Share in Overall Market

Of the key drug classes available in the global market, the segment of proton pump inhibitors is likely to acquire the dominant share in global revenue over the report’s forecast period. The segment also accounted for the dominant share in the overall market in 2016, thanks to their easy availability as over-the-counter (OTC) as well as prescription medicines and low cost.

Over the forecast period, however, the segment of acid neutralizers is expected to emerge as the most lucrative segment owing to their vast usage for occasional acidity and heartburns and their availability in the form of several flavors and formulations. Geographically, the market in Europe accounted for the dominant share in the overall market owing to the vast rise in gastro-esophageal-reflux disorders in the region.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32864

Rising Geriatric Population and Consecutive Rise in Gastroesophageal Reflux Conditions to Drive Market

The massive rise in the world’s population of geriatrics – people above the age of 60 years – has worked as one of the most favorable growth factors for the global antacids market as the demographic is highly vulnerable to peptic ulcers and gastroesophageal reflux disorders. Estimates suggest that the world geriatric population will rise to 923 mn by 2050 in Asia alone. This also suggests a potential for steady rise in demand for antacids to counter gastroesophageal reflux diseases and peptic ulcers in this population.

The market is also expected to be driven due to the vast rise in prevalence of acidity and heartburn among the global population, thanks to unhealthy dietary habits, stressful lifestyles, lack of proper sleep, and lack of physical activities. The market is also likely to benefit from the widespread practice of self-medication in cases of acidity and occasional heartburns and the easy availability of a variety of over-the-counter antacids across the globe. However, concerns associated with the adverse health effects of prolonged use of antacids could hamper the growth of the market to a certain degree.

This review of the global antacids market is based on a recent market research report by Transparency Market Research, titled “Antacids Market (Drug Class – Proton Pump Inhibitor, H2 Antagonist, and Acid Neutralizers; Formulation Type – Tablet, Liquid, and Powder; Distribution Channel – Hospital Pharmacies and Retail Pharmacies) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017–2025.”

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: https://www.transparencymarketresearch.com

Tags

Related Articles

Close